» Articles » PMID: 18515809

New-onset Atrial Fibrillation is an Independent Predictor of In-hospital Mortality in Hospitalized Heart Failure Patients: Results of the EuroHeart Failure Survey

Overview
Journal Eur Heart J
Date 2008 Jun 3
PMID 18515809
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: The prognostic significance of atrial fibrillation (AF) in hospitalized patients with heart failure (HF) remains poorly understood. To evaluate in what way AF and its different modes of presentation affect the in-hospital mortality in patients admitted with HF.

Methods And Results: The EuroHeart Failure Survey was conducted to ascertain how hospitalized HF patients are managed in Europe. The survey enrolled patients over a 6-week period in 115 hospitals from 24 countries. For this analysis, patients were categorized into three groups according to the type of AF, previous AF (patients known to have had AF prior to admission), new-onset AF (no previous AF with AF diagnosed during hospitalization), and no AF (no previous AF and no AF during hospitalization). Clinical variables, duration of hospitalization, and in-hospital survival status were assessed and compared among groups. Of the 10 701 patients included in the survey; 6027 (57%) had no AF, 3673 (34%) had previous AF, and 1001 (9%) had new-onset AF. Patients with new-onset AF had a longer stay in the intensive care unit (ICU) when compared with previous AF and no AF patients (mean 2.6 +/- 5.3, 1.2 +/- 3.5, and 1.5 +/- 4.1 days, respectively; P < 0.001). In-hospital mortality was higher among patients with new-onset AF when compared with previous AF or no AF patients (12, 7, and 7% respectively; P < 0.001). After adjusting for multiple clinical variables, new-onset AF (not previous AF) was an independent predictor of in-hospital mortality (odds ratio 1.53, 95% CI 1.1-2.0).

Conclusion: In hospitalized patients with HF, new-onset AF is an independent predictor of in-hospital mortality and a longer ICU and hospital stay.

Citing Articles

Prevalence, Risk Factors, and Mortality of New-Onset Atrial Fibrillation in Mechanically Ventilated Critically Ill Patients.

Zakynthinos G, Tsolaki V, Xanthopoulos A, Karavidas N, Vazgiourakis V, Bardaka F J Clin Med. 2024; 13(22).

PMID: 39597893 PMC: 11595098. DOI: 10.3390/jcm13226750.


Worsening Renal Function and Adverse Outcomes in Patients with HFpEF with or without Atrial Fibrillation.

Guo L, Wu X Biomedicines. 2023; 11(9).

PMID: 37760925 PMC: 10526122. DOI: 10.3390/biomedicines11092484.


The prognostic value of systemic vascular resistance in heart failure patients with permanent atrial fibrillation: a retrospective study.

Jing Z, Zhang J, Ding J, Xue Z Heart Vessels. 2023; 38(12):1431-1441.

PMID: 37743357 PMC: 10603009. DOI: 10.1007/s00380-023-02314-0.


Triggers of Atrial Fibrillation in the Geriatric Medical Intensive Care Unit: An Observational Study.

Aly K, Shaat M, Hamza S, Ali S Cardiol Res. 2023; 14(2):106-114.

PMID: 37091882 PMC: 10116932. DOI: 10.14740/cr1461.


Incidence and Clinical Outcomes of New-Onset Atrial Fibrillation in Critically lll Patients with COVID-19: A Multicenter Cohort Study - New-Onset Atrial Fibrillation and COVID-19.

Kensara R, Aljuhani O, Korayem G, Alkofide H, Almohareb S, Alosaimi Y Clin Appl Thromb Hemost. 2023; 29:10760296231156178.

PMID: 36789786 PMC: 9932755. DOI: 10.1177/10760296231156178.